<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-36546" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Substance Use in Pregnancy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Prince</surname>
            <given-names>Mary K.</given-names>
          </name>
          <aff>Novant Health Forsyth Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Daley</surname>
            <given-names>Sharon F.</given-names>
          </name>
          <aff>Cape Cod Hospital, Hyannis, MA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ayers</surname>
            <given-names>Derek</given-names>
          </name>
          <aff>Novant Health</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mary Prince declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sharon Daley declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Derek Ayers declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>21</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-36546.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Substance use and substance use disorders in pregnancy are common and linked with multiple obstetric and neonatal adverse outcomes. Ideally, all pregnant women should be screened, and those with positive screens should be promptly diagnosed and treated to avoid the morbidity and mortality associated with continued substance use during pregnancy. This activity reviews the adverse outcomes associated with the most commonly used substances and the need to collaborate with an interprofessional team to counsel, appropriately treat, and support women during their pregnancies for better outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the common adverse outcomes associated with the most commonly used substances during pregnancy.</p></list-item><list-item><p>Review the use of validated screening instruments to better identify substance use in pregnancy.</p></list-item><list-item><p>Implement the recommended treatments for substance use disorders in pregnancy.</p></list-item><list-item><p>Collaborate with an interprofessional team to counsel and support women during treatment for substance use during pregnancy for better outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=36546&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=36546">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-36546.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Perinatal substance use&#x000a0;is a significant public health issue in the United States (US) and worldwide. In the US, 40% of&#x000a0;persons with a lifetime drug use disorder and 26% with a combined alcohol and drug use disorder during the prior&#x000a0;year are women. They are at the highest risk for&#x000a0;substance use disorder during their reproductive years, and substance use during pregnancy is prevalent.&#x000a0;The most&#x000a0;frequently used substances in pregnancy are tobacco, alcohol, and marijuana, followed by cocaine and opioids.&#x000a0;Use in pregnancy is associated with multiple adverse outcomes for the mother&#x000a0;and their child.</p>
        <p>Universal screening is recommended,&#x000a0;with access to effective interventions if indicated. However, pregnant women who use substances often feel stigmatized, and barriers to evidence-based treatments exist.&#x000a0;This activity will&#x000a0;include a discussion of legal and psychosocial issues and the importance of the interprofessional team in ensuring healthy outcomes for&#x000a0;women&#x000a0;who use substances during pregnancy and their children.&#x000a0;</p>
      </sec>
      <sec id="article-36546.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Most women&#x000a0;who use substances decrease their use during pregnancy. In general, women do not choose to begin using any potentially toxic substances once they know they are pregnant. Those who can&#x000a0;quit on their own usually do so,&#x000a0;which is the distinguishing factor between substance use and substance use disorder (SUD).</p>
        <p>The etiology of SUD is multifactorial, and pregnant women are no different than the general population. Many genetic, environmental, psychological, biological, and socioeconomic factors contribute to individual susceptibility.<xref ref-type="bibr" rid="article-36546.r1">[1]</xref>&#x000a0;Tobacco and alcohol are often readily available and perceived as safe&#x000a0;because they are legal.&#x000a0;Prescription opioids, including those prescribed after delivery, contribute to opioid use disorder (OUD) by exposing women to addictive medications and making available&#x000a0;leftover pills that can be misused or diverted.<xref ref-type="bibr" rid="article-36546.r2">[2]</xref>&#x000a0;</p>
        <p>Other prescribed controlled substances like&#x000a0;amphetamines and barbiturates can&#x000a0;also lead to dependence. Illicit drugs such as heroin may be easy to obtain by those with SUD and drug-seeking behaviors. Other conditions such as poor nutrition, needle sharing, lack of safe housing, poverty, low educational level, and&#x000a0;intimate partner violence&#x000a0;are associated with&#x000a0;the diagnosis of SUD.&#x000a0;Patient-report surveys investigating the&#x000a0;influence of the environment&#x000a0;demonstrate&#x000a0;increased&#x000a0;levels of alcohol and drug use in urban&#x000a0;locales and communities with higher proportions of adolescents, young adults, and immigrants.<xref ref-type="bibr" rid="article-36546.r1">[1]</xref><xref ref-type="bibr" rid="article-36546.r3">[3]</xref></p>
      </sec>
      <sec id="article-36546.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Between 2005 and 2014, 11.5% of adolescent and 8.7% of adult pregnant women reported drinking alcohol, and 23% of adolescent and 14.9% of adult women reported using tobacco.<xref ref-type="bibr" rid="article-36546.r4">[4]</xref>&#x000a0;A US national survey in 2012 showed that 5.9% of pregnant women reported using illicit drugs, 8.5% reported drinking alcohol, and 15.9% reported smoking cigarettes during pregnancy.&#x000a0;Similar use and fetal exposure to these substances have been reported in Europe and Australia.<xref ref-type="bibr" rid="article-36546.r5">[5]</xref></p>
        <p>Retrospective reviews demonstrate that 2.5% of all pregnant women and about 20% of those with US Medicaid insurance received at least one prescription for an opioid during pregnancy.<xref ref-type="bibr" rid="article-36546.r6">[6]</xref>&#x000a0;Most pregnancies in mothers with OUD are unplanned.<xref ref-type="bibr" rid="article-36546.r7">[7]</xref>&#x000a0;Polysubstance use is&#x000a0;frequent&#x000a0;during pregnancy, similar to the general population.&#x000a0;</p>
        <p>There is a documented decrease in cigarette, alcohol, marijuana, and cocaine use during pregnancy, with most women quitting or cutting back.<xref ref-type="bibr" rid="article-36546.r8">[8]</xref>&#x000a0;</p>
        <p>SUD is&#x000a0;rarely an isolated diagnosis. It is associated with increased rates of psychiatric conditions, including major depressive, bipolar, posttraumatic stress, and panic disorder.<xref ref-type="bibr" rid="article-36546.r9">[9]</xref>&#x000a0;Comorbid human immunodeficiency virus (HIV), hepatitis B and C, tuberculosis, and sexually transmitted infections&#x000a0;occur due to an association with multiple sex partners, sharing drug paraphernalia, homelessness, and increased incarceration rates.<xref ref-type="bibr" rid="article-36546.r10">[10]</xref><xref ref-type="bibr" rid="article-36546.r11">[11]</xref></p>
      </sec>
      <sec id="article-36546.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Substance use and SUD in pregnancy are associated with&#x000a0;significant&#x000a0;maternal, fetal, and neonatal pathology, depending on the substances involved. Explaining the pathophysiological consequences of each substance is beyond the scope of this activity.</p>
      </sec>
      <sec id="article-36546.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The fifth edition of the&#x000a0;Diagnostic and Statistical Manual of Mental Disorders (DSM-5) combined the substance abuse and dependence criteria to&#x000a0;diagnose SUD.<xref ref-type="bibr" rid="article-36546.r12">[12]</xref>&#x000a0;The presence of two or more in the preceding 12 months is diagnostic of SUD:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>hazardous use</p>
          </list-item>
          <list-item>
            <p>social/interpersonal problems&#x000a0;due to using</p>
          </list-item>
          <list-item>
            <p>neglect&#x000a0;of expected roles</p>
          </list-item>
          <list-item>
            <p>withdrawal</p>
          </list-item>
          <list-item>
            <p>tolerance</p>
          </list-item>
          <list-item>
            <p>using&#x000a0;more or for longer than intended</p>
          </list-item>
          <list-item>
            <p>repeated attempts to quit</p>
          </list-item>
          <list-item>
            <p>related physical/psychological problems</p>
          </list-item>
          <list-item>
            <p>craving</p>
          </list-item>
          <list-item>
            <p>use preferred over other activities</p>
          </list-item>
        </list>
        <p>A comprehensive medical history and a complete physical examination are the first steps in establishing the diagnosis of SUD. Some pregnant women readily admit to substance use,&#x000a0;but others may be reluctant to disclose this sensitive information due to fear of repercussions, judgmental treatment, and social services involvement. When a stated history of substance use is absent, other features of the medical history can&#x000a0;point to possible SUD, including a history of endocarditis, HIV, hepatitis C, sexual and/or physical abuse, and psychiatric conditions. A pregnant woman with late or no prenatal care may have avoided&#x000a0;appointments due to concerns about revealing&#x000a0;her&#x000a0;substance use and the perceived adverse consequences. Many fear arrest, prosecution, and loss of child custody.</p>
        <p>Physical examination begins with vital signs, with hypertension being a clue&#x000a0;for possible cocaine or amphetamine use. Nasal septal perforation may be an additional clue&#x000a0;for cocaine use. An underweight patient may be malnourished due to drugs or alcohol. Clinical staff, including medical assistants, nurses, nurse practitioners, physician assistants, and physicians, should&#x000a0;observe the patient's general appearance. Women who&#x000a0;are obtunded, agitated, or sleepy may be under the influence of substances. Dilated or&#x000a0;constricted pupils and injection marks&#x000a0;on the skin&#x000a0;suggest possible opioid use. Bruises should elicit questions about maltreatment. If a pregnant woman smells strongly of tobacco, alcohol, or marijuana, she should be asked specifically about these substances in a confidential setting. Another frequent but nonspecific physical finding is poor dentition.&#x000a0;</p>
      </sec>
      <sec id="article-36546.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Substance use in pregnancy is a common condition with substantial complications. A thorough medical history and physical examination will often lead to a diagnosis of SUD or reveal concerning substance use that does not meet the DSM-5 criteria for SUD. However, many women will not disclose sensitive information about their substance use, so clinicians&#x000a0;must rely on other methods to identify&#x000a0;those at risk.</p>
        <p>The American College of Obstetricians and Gynecologists (ACOG) recommends early, universal screening for substance use as part of comprehensive prenatal care in partnership with pregnant women.<xref ref-type="bibr" rid="article-36546.r13">[13]</xref>&#x000a0;In fact, most developed countries advocate for universal screening.<xref ref-type="bibr" rid="article-36546.r14">[14]</xref>&#x000a0;If women are screened only when a medical provider suspects drug or alcohol use, many patients will be missed. A validated screening instrument that is easy to administer, acceptable, and economical should be used. Barriers exist, including the perception that screening will offend women and&#x000a0;insufficient time during an office visit to counsel and refer those whose screen is positive. In general, no&#x000a0;screening instrument is superior; three free and easy-to-use screens are the NIDA Quick Screen, 4 Ps, and CRAFFT (for women&#x000a0;younger than 27).<xref ref-type="bibr" rid="article-36546.r15">[15]</xref> The T-ACE and T-ACER 3 screens are specific for alcohol use in pregnancy.<xref ref-type="bibr" rid="article-36546.r16">[16]</xref> These validated screening&#x000a0;instruments&#x000a0;are readily available online. Trained clinical staff, including medical assistants and nurses, can&#x000a0;administer the selected screening instrument. ACOG recommends an initial screening at the first prenatal visit, and many practitioners repeat screening at designated intervals during&#x000a0;subsequent visits.&#x000a0;</p>
        <p>A&#x000a0;positive screen cannot be considered diagnostic of SUD in pregnancy.&#x000a0;False positive and false negative results occur, and screening may reveal occasional substance use rather than SUD. The clinician's next step is a conversation regarding the frequency of substance use and&#x000a0;whether there is any current use.&#x000a0;It is essential to&#x000a0;counsel pregnant women about the risks to&#x000a0;themselves and their&#x000a0;children and discourage further use. When SUD is suspected or confirmed,&#x000a0;it is essential to provide information about local resources for counseling and treatment in a nonjudgmental manner. Medical providers should never assume family members or significant others know about a woman's substance use, and respecting patient confidentiality is of utmost importance. Clinicians should also be knowledgeable about local&#x000a0;and state reporting requirements. SUD is a medical condition, not a moral failing, and punitive attitudes&#x000a0;can negatively impact maternal&#x000a0;and neonatal outcomes. Women with SUD who feel stigmatized may avoid continuing essential prenatal care.</p>
        <p>Screening is often confused with drug or alcohol testing. Universal screening, but not routine drug or alcohol toxicology testing, is recommended in pregnant women. Screening&#x000a0;is a test used for at-risk populations, including those without symptoms. However, testing for biological markers of substance use may be indicated in specific situations, especially when objective&#x000a0;or specific information about multiple substances is required. Urine, hair, and meconium samples have shown adequate sensitivity as biological markers of substance use. Urine drug screening mainly detects recent use.<xref ref-type="bibr" rid="article-36546.r17">[17]</xref> Neonatal hair and meconium testing can reveal intrauterine use&#x000a0;in the second and third trimesters.<xref ref-type="bibr" rid="article-36546.r18">[18]</xref>&#x000a0;Maternal consent, except in life-threatening situations, is required before performing drug testing during pregnancy.<xref ref-type="bibr" rid="article-36546.r18">[18]</xref>&#x000a0;</p>
        <p>Mandated biological testing may be required for women in treatment programs or involved with the legal system. Drug testing does not&#x000a0;distinguish between regular and occasional substance use and should be based&#x000a0;on medical criteria rather than demographic profiling. Testing in the hospital&#x000a0;during labor and delivery&#x000a0;must occur before administering&#x000a0;prescription medications that may produce a positive result. Each community has trends in drug use,&#x000a0;which should be reflected in local and hospital laboratories' testing panels. False-positive test&#x000a0;results have been linked to ingesting poppy seeds and dextromethorphan.<xref ref-type="bibr" rid="article-36546.r19">[19]</xref><xref ref-type="bibr" rid="article-36546.r20">[20]</xref>&#x000a0;False-negative results occur when patients substitute someone else's urine for their own. An astute laboratory technician or nurse may notice that the&#x000a0;sample&#x000a0;provided by the patient is cool or at room temperature rather than body temperature and question the specimen's origin.</p>
      </sec>
      <sec id="article-36546.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The optimal management strategy for&#x000a0;pregnant women with substance use or&#x000a0;SUD begins with comprehensive prenatal care.&#x000a0;The next step is counseling and educating&#x000a0;them&#x000a0;about the consequences of tobacco, alcohol,&#x000a0;and drug use&#x000a0;related to&#x000a0;themself&#x000a0;and their unborn&#x000a0;child and encouraging&#x000a0;them to discontinue or reduce usage. Motivational interviewing and brief intervention rather than a judgmental or punitive approach are more likely to produce positive behavioral change. All women with SUD should be referred to the appropriate provider without delay for comprehensive behavioral and medical treatment.</p>
        <p>Treatment&#x000a0;of all types of SUD reduces the risk of relapse and improves pregnancy outcomes. ACOG recommends that pregnant women who smoke or use nicotine and tobacco products quit. Babies born to women who abstain by 15 weeks of gestation benefit the most. When behavioral counseling does not&#x000a0;result in smoking cessation, varenicline, bupropion, and nicotine replacement can be considered, but these treatments lack safety data for use in pregnancy. Varenicline and bupropion are both FDA category C medications. Nicotine replacement during pregnancy has not been&#x000a0;proven to result in long-term smoking cessation.<xref ref-type="bibr" rid="article-36546.r21">[21]</xref>&#x000a0;</p>
        <p>Patients with alcohol or benzodiazepine use disorder can be managed with detoxification using a diazepam or lorazepam taper.<xref ref-type="bibr" rid="article-36546.r18">[18]</xref>&#x000a0;Approved medications for alcohol use disorder include naltrexone, disulfiram, and acamprosate. However, they are category C medications with no human data to support safety during pregnancy, and animal studies&#x000a0;show adverse and possible teratogenic effects.<xref ref-type="bibr" rid="article-36546.r22">[22]</xref>&#x000a0;Alcohol withdrawal syndrome is dangerous and potentially life-threatening, resulting in seizures and delirium tremens, and patients with withdrawal should&#x000a0;receive&#x000a0;inpatient detoxification.<xref ref-type="bibr" rid="article-36546.r23">[23]</xref>&#x000a0;</p>
        <p>Medication-assisted treatment is the standard of care for pregnant women with OUD. Although some women choose&#x000a0;medically supervised withdrawal, current guidelines recommend treatment with methadone or buprenorphine. There is a higher rate of relapse during pregnancy in women who&#x000a0;elect detoxification rather than medication-assisted treatment.<xref ref-type="bibr" rid="article-36546.r24">[24]</xref> Naltrexone, an opioid receptor antagonist, is also approved for OUD, but insufficient data exist to recommend initiating the medication during pregnancy. However, when a pregnant woman is already treated with naltrexone, she may elect to continue it&#x000a0;after&#x000a0;reviewing&#x000a0;potential risks and benefits with her clinician and with close medical supervision.<xref ref-type="bibr" rid="article-36546.r25">[25]</xref></p>
        <p>Medication-assisted treatment suppresses cravings and withdrawal symptoms, and patients are less likely to use illicit&#x000a0;substances when enrolled in a treatment program. Pregnant women&#x000a0;better adhere to prenatal care recommendations and&#x000a0;experience&#x000a0;fewer complications associated with intravenous drug use, such as overdose and infection. However, many pregnant women with OUD&#x000a0;struggle to access medication-assisted treatment compared to their non-pregnant peers, especially those living in rural areas, non-English speakers, and those not covered by health insurance.<xref ref-type="bibr" rid="article-36546.r24">[24]</xref><xref ref-type="bibr" rid="article-36546.r26">[26]</xref><xref ref-type="bibr" rid="article-36546.r27">[27]</xref></p>
        <p>The decision to&#x000a0;prescribe either buprenorphine or methadone depends on many factors, including the availability of treatment programs and whether the patient prefers daily supervised medication appointments or a prescription to be taken at home.<xref ref-type="bibr" rid="article-36546.r28">[28]</xref><xref ref-type="bibr" rid="article-36546.r29">[29]</xref>&#x000a0;Methadone is a long-acting, full mu-receptor agonist and, in the US, must be dispensed at a federally accredited opioid treatment program under direct&#x000a0;supervision. Patients require access to a local program and reliable transportation. Methadone reduces HIV risks and fetal mortality and increases birth weight and adherence to prenatal care.&#x000a0;Buprenorphine is a partial mu-receptor agonist and can be prescribed in office-based settings. Patients may take oral or sublingual&#x000a0;buprenorphine at home, with regular follow-up office visits. They do not&#x000a0;need daily transportation to a treatment facility, but there is a risk of medication diversion and non-compliance. Prescribers must&#x000a0;know&#x000a0;about&#x000a0;local resources and patient-specific factors to determine&#x000a0;the best treatment plan for each patient.&#x000a0;</p>
        <p>
<bold>Mainstreaming Addiction Treatment (MAT) Act</bold>
</p>
        <p>The Mainstreaming Addiction Treatment (MAT) Act provision updates federal guidelines to expand the availability of evidence-based treatment to address the opioid epidemic. The MAT Act empowers all health care providers with a standard controlled substance license to prescribe buprenorphine for opioid use disorder (OUD), just as they prescribe other essential medications. The MAT Act is intended to help destigmatize a standard of care for OUD and will integrate substance use disorder treatment across healthcare settings.&#x000a0;</p>
        <p>As of December 2022, the MAT Act has eliminated the DATA-Waiver (X-Waiver) program. All DEA-registered practitioners with Schedule III authority may now prescribe buprenorphine for OUD in their practice if permitted by applicable state law, and SAMHSA encourages them to do so. Prescribers who were registered as DATA-Waiver prescribers will receive a new DEA registration certificate reflecting this change; no action is needed on the part of registrants.</p>
        <p>There are no longer any limits on the number of patients with OUD that a practitioner may treat with buprenorphine. Separate tracking of patients treated with buprenorphine or prescriptions written is no longer required.&#x000a0;</p>
        <p>Pharmacy staff can now fill buprenorphine prescriptions using the prescribing authority's DEA number and does not need a DATA 2000 waiver from the prescriber. However, depending on the pharmacy, the dispensing software may still require the X-Waiver information in order to proceed. Practitioners are still required to comply with any applicable state limits regarding the treatment of patients with OUD.&#x000a0; Contact information for State Opioid Treatment Authorities can be found here: https://www.samhsa.gov/medicationassisted-treatment/sota.&#x000a0;&#x000a0;</p>
        <p>
<bold>Neonatal opioid withdrawal syndrome (NOWS)</bold>
</p>
        <p>Neonatal opioid withdrawal syndrome (NOWS), previously referred to as neonatal abstinence syndrome (NAS), is an expected and&#x000a0;manageable condition in newborns with&#x000a0;prenatal opioid exposure. Treatment with&#x000a0;methadone and buprenorphine during pregnancy can decrease the severity of NOWS. Some studies demonstrate that newborns exposed to prenatal buprenorphine require less medication and have a shorter&#x000a0;hospital stay than&#x000a0;those exposed to methadone.<xref ref-type="bibr" rid="article-36546.r30">[30]</xref> They may also have a slightly improved birth weight and gestational age.<xref ref-type="bibr" rid="article-36546.r31">[31]</xref>&#x000a0;</p>
        <p>Medication-assisted treatment has not been associated with congenital malformations, and studies show minimal to no long-term neurodevelopmental adverse outcomes in exposed infants.<xref ref-type="bibr" rid="article-36546.r32">[32]</xref><xref ref-type="bibr" rid="article-36546.r33">[33]</xref>&#x000a0;Symptom onset often occurs&#x000a0;within 12 to 24 hours with heroin exposure but between 48 and 72 hours with medication-assisted treatment. Occasionally, infants do not exhibit symptoms until aged 5 to 7 days. Some studies correlate the dose of&#x000a0;medication-assisted treatment with the severity and incidence of NOWS, but others find no association.<xref ref-type="bibr" rid="article-36546.r34">[34]</xref><xref ref-type="bibr" rid="article-36546.r35">[35]</xref>&#x000a0;</p>
        <p>Women who begin medication-assisted treatment before or early in pregnancy are more likely to receive comprehensive prenatal care, follow medical recommendations, and deliver healthier babies. They are also less likely to relapse&#x000a0;or&#x000a0;acquire sexually transmitted infections. Medication-assisted treatment should be readily available to all pregnant women identified with OUD to improve maternal and infant outcomes.</p>
        <p>
<bold>Breastfeeding</bold>
</p>
        <p>Women who breastfeed and "room-in" with their newborns require less pain medication after delivery. Breastfeeding is associated with a decreased severity of NOWS symptoms and&#x000a0;a decreased need for pharmacotherapy&#x000a0;for&#x000a0;affected newborns.<xref ref-type="bibr" rid="article-36546.r36">[36]</xref><xref ref-type="bibr" rid="article-36546.r37">[37]</xref>&#x000a0;However, it is not recommended when women use illicit substances, including marijuana, because traces can be found in breast milk. Few controlled studies exist on marijuana in breastfeeding women, and it is difficult to separate prenatal from breast milk exposure. Without data supporting its safety, ACOG and the American Academy of Pediatrics (AAP) regard abstaining as prudent.<xref ref-type="bibr" rid="article-36546.r38">[38]</xref></p>
        <p>Women with hepatitis C&#x000a0;should breastfeed unless they have cracked or bleeding nipples, but it&#x000a0;is&#x000a0;generally contraindicated for mothers with HIV.<xref ref-type="bibr" rid="article-36546.r39">[39]</xref><xref ref-type="bibr" rid="article-36546.r40">[40]</xref>&#x000a0;However, the World Health Organization recommends that mothers infected with HIV in developing countries who are treated with&#x000a0;combined antiretroviral therapy (cART) should breastfeed their infants&#x000a0;because breast milk is likely&#x000a0;more nutritious than available alternatives.</p>
        <p>Occasionally, a new mother will feel uncomfortable breastfeeding, especially if she has a history of intimate partner violence.&#x000a0;Clinicians should respect and support her decision&#x000a0;to nourish her baby with formula.&#x000a0;</p>
      </sec>
      <sec id="article-36546.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis&#x000a0;is based on the particular substance(s) being used during the pregnancy.</p>
        <p>If&#x000a0;the medical history, physical examination, validated screening, or biological testing reveals substance use, the&#x000a0;next&#x000a0;step is to distinguish between occasional or prescription usage and SUD. If a woman is diagnosed with SUD, she should be evaluated for single versus polysubstance use because the consequences and treatment differ, depending on the substances involved. The clinician must search for common comorbid conditions related to SUD, including sexually transmitted infections such as HIV. Individuals with SUD also have higher rates of&#x000a0;mental health disorders than the general population. Diagnosing&#x000a0;psychiatric conditions may be difficult before initiating SUD treatment due to overlapping symptoms. In addition, poor nutrition and dental hygiene often accompany SUD.</p>
        <p>Clinicians who listen carefully, perform a complete physical examination, and screen with a validated&#x000a0;instrument are more likely to diagnose SUD early and initiate appropriate treatment. Pregnant women with SUD must be evaluated for coexisting conditions&#x000a0;that can adversely impact the pregnancy if not diagnosed and promptly managed. A high index of suspicion for SUD will lead to early treatment and improved outcomes for both mother and her child.</p>
      </sec>
      <sec id="article-36546.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Abstinence and medication-assisted treatment improve outcomes for pregnant women and their children. Pregnancy is a strong motivator for abstinence, and most women refrain from or decrease their use of tobacco, alcohol, marijuana, and cocaine by the second trimester.&#x000a0;Those with OUD receiving medication-assisted treatment, enrolled&#x000a0;in a comprehensive program&#x000a0;with behavioral counseling and psychosocial support, usually maintain sobriety until delivery. However, postpartum relapse is frequent, especially for tobacco, marijuana, and alcohol, with rates as high as 80% in the first year after giving birth.<xref ref-type="bibr" rid="article-36546.r8">[8]</xref>&#x000a0;Following delivery, a combination of sleep deprivation, hormonal shifts, and caring for an infant causes&#x000a0;stress, making ongoing recovery challenging. Postpartum unintentional overdoses contribute to maternal mortality, and women should be followed closely&#x000a0;during the first postpartum year.<xref ref-type="bibr" rid="article-36546.r41">[41]</xref></p>
      </sec>
      <sec id="article-36546.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Tobacco use increases the risk of stillbirth, fetal growth restriction, decreased birth weight, prematurity, and sudden unexplained infant death.<xref ref-type="bibr" rid="article-36546.r42">[42]</xref><xref ref-type="bibr" rid="article-36546.r43">[43]</xref>&#x000a0;Smoking is associated with attention deficit/hyperactivity disorder in childhood, but studies confirming causation are lacking.<xref ref-type="bibr" rid="article-36546.r44">[44]</xref></p>
        <p>No amount of alcohol is deemed safe during pregnancy, and&#x000a0;drinking may result in fetal alcohol syndrome (FAS) and congenital malformations. Like tobacco, alcohol may be perceived as safe and socially acceptable because it is legal. As many as 13.5% of pregnant women have consumed alcohol in the previous month, according to the Centers for Disease Control. Alcohol is a known teratogen, and FAS is the leading cause of preventable intellectual disability in the US.<xref ref-type="bibr" rid="article-36546.r22">[22]</xref>&#x000a0;</p>
        <p>Marijuana is a federally banned substance in the US,&#x000a0;but legal in many states. Randomized, controlled studies during&#x000a0;pregnancy are lacking, but there is evidence of an association with stillbirth, decreased birth weight, and preterm birth.<xref ref-type="bibr" rid="article-36546.r45">[45]</xref><xref ref-type="bibr" rid="article-36546.r46">[46]</xref>&#x000a0;Direct causal evidence is lacking, but there is a concern about poorer cognitive outcomes in school-aged children.<xref ref-type="bibr" rid="article-36546.r38">[38]</xref>&#x000a0;One study reported that maternal marijuana use during pregnancy did not predict adverse neonatal outcomes after adjusting for concomitant tobacco use and other confounding factors.<xref ref-type="bibr" rid="article-36546.r47">[47]</xref>&#x000a0;However, a recent review and meta-analysis reported increased adverse outcomes in neonates exposed to marijuana in-utero.<xref ref-type="bibr" rid="article-36546.r48">[48]</xref>&#x000a0;These included a birth weight&#x000a0;under 2500 grams, decreased mean birth weight, small for gestational age, prematurity,&#x000a0;lower Apgar score at 1 minute, and&#x000a0;smaller mean head circumference.<xref ref-type="bibr" rid="article-36546.r48">[48]</xref>&#x000a0;ACOG and the AAP advise avoiding marijuana due to the possible neurodevelopmental impact on the developing fetus.<xref ref-type="bibr" rid="article-36546.r49">[49]</xref></p>
        <p>Cocaine use is associated with maternal hypertension and placental abruption and may result in low birth weight, small for gestational age, and prematurity in neonates.<xref ref-type="bibr" rid="article-36546.r50">[50]</xref><xref ref-type="bibr" rid="article-36546.r51">[51]</xref>&#x000a0;Researchers have established a link between cocaine use and growth&#x000a0;deceleration involving all parameters, with a more pronounced effect in late gestation.<xref ref-type="bibr" rid="article-36546.r52">[52]</xref>&#x000a0;</p>
        <p>Amphetamines are associated with increased maternal and fetal morbidity and mortality, including maternal hypertension, preeclampsia, placental&#x000a0;abruption, fetal demise, and neonatal death.<xref ref-type="bibr" rid="article-36546.r53">[53]</xref></p>
        <p>Opioids, both illicit and prescribed, can cause NOWS, which affects the newborn's central nervous, autonomic, respiratory, and gastrointestinal systems and may&#x000a0;lead to prolonged hospitalization.<xref ref-type="bibr" rid="article-36546.r54">[54]</xref> Early signs and symptoms include irritability, poor feeding, temperature instability, and difficulty sleeping.&#x000a0;Prenatal opioid use also increases the risk of low birth weight and neonates who are small for gestational age.<xref ref-type="bibr" rid="article-36546.r55">[55]</xref><xref ref-type="bibr" rid="article-36546.r56">[56]</xref><xref ref-type="bibr" rid="article-36546.r57">[57]</xref></p>
        <p>Legal&#x000a0;issues can also occur with substance use during pregnancy. Eighteen states in the US define substance use as child abuse, and three consider it grounds for commitment. Many&#x000a0;women fear arrest, prosecution, and loss of custody and therefore avoid prenatal care or do not disclose their substance use to their medical providers. Some states mandate reporting&#x000a0;all illicit or prescribed substance use, including marijuana and medication-assisted treatment, to Child Protective Services. Clinicians must know their local testing and reporting requirements&#x000a0;and&#x000a0;share this information with their pregnant patients while advocating for holistic and comprehensive care. Criminalizing substance use will not lead to improved clinical outcomes for mothers&#x000a0;or their children.&#x000a0;</p>
      </sec>
      <sec id="article-36546.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education regarding maternal and neonatal complications&#x000a0;of substance use in pregnancy is essential. Comprehensive prenatal and postnatal care, including behavioral counseling and psychosocial support, improves clinical outcomes.<xref ref-type="bibr" rid="article-36546.r14">[14]</xref>&#x000a0;Childbearing-aged women should receive information about the dangers of prenatal substance use, including alcohol, tobacco, and marijuana because&#x000a0;many pregnancies are unplanned. For women with OUD, initiating medication-assisted treatment before pregnancy is&#x000a0;a recommended public health approach.&#x000a0;</p>
        <p>Women whose&#x000a0;newborns are at risk for NOWS benefit from&#x000a0;learning what to expect after delivery. Nurses and other clinicians can discuss newborn withdrawal symptoms, comfort measures, breastfeeding, pharmacotherapy options, and the need for&#x000a0;close observation. Many labor and delivery units offer prenatal tours to mothers with OUD to prepare them for their perinatal experience.&#x000a0;</p>
        <p>Patient education, counseling, and monitoring do not end with delivery. Women with SUD&#x000a0;are at high risk for postpartum relapse and&#x000a0;must be educated&#x000a0;about the&#x000a0;dangers of resuming substance use after delivery. They should be screened and closely monitored, especially during the first postpartum year. Continued medication-assisted treatment and consultation with substance use specialists and behavior therapists will help achieve&#x000a0;optimal outcomes.<xref ref-type="bibr" rid="article-36546.r8">[8]</xref>&#x000a0;Broadly defined, patient education includes information and access to resources for transportation, safe housing, food security, childcare, and contraception. Trauma-informed counseling and peer recovery support groups can also improve the chances of&#x000a0;sobriety following delivery.<xref ref-type="bibr" rid="article-36546.r58">[58]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-36546.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Caring for women with substance use during pregnancy can be rewarding, challenging, complex, and time-consuming. A holistic approach to comprehensive care requires an interprofessional team. Nurses, nurse practitioners, physician assistants, physicians, midwives, social workers, pharmacists, and mental health&#x000a0;and addiction medicine specialists who work together as a cohesive interprofessional team can&#x000a0;improve outcomes for mothers and their children. Prenatal screening for substance use can be performed by nursing staff in the office setting.&#x000a0;Nurses can also educate pregnant women about substance use, medication-assisted treatment, NOWS, and the advantages of breastfeeding.&#x000a0;</p>
        <p>Many hospitals employ the LDRP model, where the same nurses care for the mother during labor, delivery, recovery, and postpartum.&#x000a0;Nurses are often the first to notice a new mother having difficulty caring for her newborn, especially if experiencing side effects of medication-assisted treatment, such as&#x000a0;falling asleep while holding her child. Pregnant women, due to a greater volume of distribution and rate of metabolism, often require more methadone during pregnancy, and the dose&#x000a0;might need adjustment after delivery.<xref ref-type="bibr" rid="article-36546.r32">[32]</xref>&#x000a0;An astute nurse observes maternal medication side effects&#x000a0;and early signs of neonatal withdrawal. Everyone who cares for the mother-infant dyad is part of the team.</p>
        <p>Many programs conduct multidisciplinary rounds regularly, with&#x000a0;professionals from obstetrics, pediatrics, pharmacy, and social work discussing the care of all mothers and their newborns. Social workers assist with assessing the social determinants of health, including housing, food insecurity, and transportation, and preparing mothers for the possible involvement of Child Protective Services.&#x000a0;</p>
        <p>A model perinatal program at the Dartmouth-Hitchcock Medical Center combines&#x000a0;midwifery services&#x000a0;and&#x000a0;addiction treatment. This model provides specialized care for women during pregnancy and the postpartum year&#x000a0;and recognizes this population's unique and challenging needs. The program has led to&#x000a0;better access to prenatal care, continuity of care, and family planning services.<xref ref-type="bibr" rid="article-36546.r59">[59]</xref>&#x000a0;</p>
        <p>The interprofessional healthcare team can&#x000a0;improve&#x000a0;care for pregnant women with substance use and SUD. SUD is a complex medical condition requiring empathy, knowledge, and skills from&#x000a0;a team of caregivers working together. Implementing universal screening, overcoming barriers to treatment, addressing psychosocial needs,&#x000a0;establishing an early diagnosis, and initiating medication-assisted treatment when&#x000a0;appropriate will result in healthier outcomes for mothers and their children.</p>
      </sec>
      <sec id="article-36546.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=36546&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=36546">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/child-health/substance-use-in-pregnancy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=36546">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/36546/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=36546">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-36546.s15">
        <title>References</title>
        <ref id="article-36546.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prom-Wormley</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Ebejer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Bowers</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>The genetic epidemiology of substance use disorder: A review.</article-title>
            <source>Drug Alcohol Depend</source>
            <year>2017</year>
            <month>Nov</month>
            <day>01</day>
            <volume>180</volume>
            <fpage>241</fpage>
            <page-range>241-259</page-range>
            <pub-id pub-id-type="pmid">28938182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Badreldin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Grobman</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Yee</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Opioid prescribing patterns among postpartum women.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>219</volume>
            <issue>1</issue>
            <fpage>103.e1</fpage>
            <page-range>103.e1-103.e8</page-range>
            <pub-id pub-id-type="pmid">29630887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mannelli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Swartz</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.</article-title>
            <source>Drug Alcohol Depend</source>
            <year>2017</year>
            <month>Aug</month>
            <day>01</day>
            <volume>177</volume>
            <fpage>153</fpage>
            <page-range>153-162</page-range>
            <pub-id pub-id-type="pmid">28599214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reingle Gonzalez</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Salas-Wright</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Vaughn</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>DiNitto</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and correlates of alcohol and tobacco use among pregnant women in the United States: Evidence from the NSDUH 2005-2014.</article-title>
            <source>Prev Med</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>97</volume>
            <fpage>93</fpage>
            <page-range>93-99</page-range>
            <pub-id pub-id-type="pmid">28111096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forray</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Substance use during pregnancy.</article-title>
            <source>F1000Res</source>
            <year>2016</year>
            <volume>5</volume>
            <pub-id pub-id-type="pmid">27239283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desai</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Hernandez-Diaz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bateman</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Huybrechts</surname>
                <given-names>KF</given-names>
              </name>
            </person-group>
            <article-title>Increase in prescription opioid use during pregnancy among Medicaid-enrolled women.</article-title>
            <source>Obstet Gynecol</source>
            <year>2014</year>
            <month>May</month>
            <volume>123</volume>
            <issue>5</issue>
            <fpage>997</fpage>
            <page-range>997-1002</page-range>
            <pub-id pub-id-type="pmid">24785852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elmore</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Omofuma</surname>
                <given-names>OO</given-names>
              </name>
              <name>
                <surname>Sevoyan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Richard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Prescription opioid use among women of reproductive age in the United States: NHANES, 2003-2018.</article-title>
            <source>Prev Med</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>153</volume>
            <fpage>106846</fpage>
            <pub-id pub-id-type="pmid">34653502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forray</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Merry</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ruger</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Yonkers</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Perinatal substance use: a prospective evaluation of abstinence and relapse.</article-title>
            <source>Drug Alcohol Depend</source>
            <year>2015</year>
            <month>May</month>
            <day>01</day>
            <volume>150</volume>
            <fpage>147</fpage>
            <page-range>147-55</page-range>
            <pub-id pub-id-type="pmid">25772437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Costello</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yonkers</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Clinical correlates of prescription opioid analgesic use in pregnancy.</article-title>
            <source>Matern Child Health J</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>548</fpage>
            <page-range>548-56</page-range>
            <pub-id pub-id-type="pmid">24951127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Testa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fahmy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Incarceration exposure and prescription opioid use during pregnancy.</article-title>
            <source>Drug Alcohol Depend</source>
            <year>2022</year>
            <month>Jun</month>
            <day>01</day>
            <volume>235</volume>
            <fpage>109434</fpage>
            <pub-id pub-id-type="pmid">35405460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nordholm</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Wejse</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Norman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ekstr&#x000f8;m</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lillebaek</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Mental illness, substance abuse, and tuberculosis risk.</article-title>
            <source>J Infect</source>
            <year>2023</year>
            <month>May</month>
            <volume>86</volume>
            <issue>5</issue>
            <fpage>e135</fpage>
            <page-range>e135-e137</page-range>
            <pub-id pub-id-type="pmid">36716977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasin</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Auriacombe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borges</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bucholz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Budney</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Compton</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Crowley</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Petry</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Schuckit</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>BF</given-names>
              </name>
            </person-group>
            <article-title>DSM-5 criteria for substance use disorders: recommendations and rationale.</article-title>
            <source>Am J Psychiatry</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>170</volume>
            <issue>8</issue>
            <fpage>834</fpage>
            <page-range>834-51</page-range>
            <pub-id pub-id-type="pmid">23903334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <article-title>Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>e81</fpage>
            <page-range>e81-e94</page-range>
            <pub-id pub-id-type="pmid">28742676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsakiridis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Oikonomidou</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Bakaloudi</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Dagklis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Papazisis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chourdakis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Substance Use During Pregnancy: A Comparative Review of Major Guidelines.</article-title>
            <source>Obstet Gynecol Surv</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>76</volume>
            <issue>10</issue>
            <fpage>634</fpage>
            <page-range>634-643</page-range>
            <pub-id pub-id-type="pmid">34724075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coleman-Cowger</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Oga</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Trocin</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Koszowski</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mark</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of Three Screening Tools for Prenatal Substance Use.</article-title>
            <source>Obstet Gynecol</source>
            <year>2019</year>
            <month>May</month>
            <volume>133</volume>
            <issue>5</issue>
            <fpage>952</fpage>
            <page-range>952-961</page-range>
            <pub-id pub-id-type="pmid">30969217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dozet</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Burd</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Popova</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Screening for Alcohol Use in Pregnancy: a Review of Current Practices and Perspectives.</article-title>
            <source>Int J Ment Health Addict</source>
            <year>2023</year>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>1220</fpage>
            <page-range>1220-1239</page-range>
            <pub-id pub-id-type="pmid">34580577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yonkers</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Howell</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Gotman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rounsaville</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Self-report of illicit substance use versus urine toxicology results from at-risk pregnant women.</article-title>
            <source>J Subst Use</source>
            <year>2011</year>
            <month>Oct</month>
            <day>01</day>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>372</fpage>
            <page-range>372-389</page-range>
            <pub-id pub-id-type="pmid">23956685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ordean</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kahan</surname>
                <given-names>M</given-names>
              </name>
              <collab>MATERNAL FETAL MEDICINE COMMITTEE</collab>
              <collab>FAMILY PHYSICIANS ADVISORY COMMITTEE</collab>
              <collab>MEDICO-LEGAL COMMITTEE</collab>
              <collab>AD HOC REVIEWERS</collab>
              <collab>SPECIAL CONTRIBUTORS</collab>
            </person-group>
            <article-title>Substance use in pregnancy.</article-title>
            <source>J Obstet Gynaecol Can</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>367</fpage>
            <page-range>367-384</page-range>
            <pub-id pub-id-type="pmid">21501542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reisfield</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Teitelbaum</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Poppy Seed Consumption May Be Associated with Codeine-Only Urine Drug Test Results.</article-title>
            <source>J Anal Toxicol</source>
            <year>2023</year>
            <month>Mar</month>
            <day>21</day>
            <volume>47</volume>
            <issue>2</issue>
            <fpage>107</fpage>
            <page-range>107-113</page-range>
            <pub-id pub-id-type="pmid">36181466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brahm</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Yeager</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Farmer</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Commonly prescribed medications and potential false-positive urine drug screens.</article-title>
            <source>Am J Health Syst Pharm</source>
            <year>2010</year>
            <month>Aug</month>
            <day>15</day>
            <volume>67</volume>
            <issue>16</issue>
            <fpage>1344</fpage>
            <page-range>1344-50</page-range>
            <pub-id pub-id-type="pmid">20689123</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <article-title>Tobacco and Nicotine Cessation During Pregnancy: ACOG Committee Opinion, Number 807.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>May</month>
            <volume>135</volume>
            <issue>5</issue>
            <fpage>e221</fpage>
            <page-range>e221-e229</page-range>
            <pub-id pub-id-type="pmid">32332417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeVido</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bogunovic</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Alcohol use disorders in pregnancy.</article-title>
            <source>Harv Rev Psychiatry</source>
            <year>2015</year>
            <season>Mar-Apr</season>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>112</fpage>
            <page-range>112-21</page-range>
            <pub-id pub-id-type="pmid">25747924</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bacon</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Robert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>VandenBerg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Evaluating nursing satisfaction and utilization of the Clinical Institute Withdrawal Assessment for Alcohol, revised version (CIWA-Ar).</article-title>
            <source>Ment Health Clin</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>114</fpage>
            <page-range>114-119</page-range>
            <pub-id pub-id-type="pmid">29955457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Klie</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Pharmacological treatment of opioid use disorder in pregnancy.</article-title>
            <source>Semin Perinatol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>141</fpage>
            <page-range>141-148</page-range>
            <pub-id pub-id-type="pmid">30755340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Towers</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Weitz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Visconti</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Use of naltrexone in treating opioid use disorder in pregnancy.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>222</volume>
            <issue>1</issue>
            <fpage>83.e1</fpage>
            <page-range>83.e1-83.e8</page-range>
            <pub-id pub-id-type="pmid">31376396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Short</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Hand</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>MacAfee</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Abatemarco</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Terplan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States.</article-title>
            <source>J Subst Abuse Treat</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>89</volume>
            <fpage>67</fpage>
            <page-range>67-74</page-range>
            <pub-id pub-id-type="pmid">29706175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patrick</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Dupont</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>McNeer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Buntin</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Leech</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Lovell</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>WO</given-names>
              </name>
            </person-group>
            <article-title>Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder.</article-title>
            <source>JAMA Netw Open</source>
            <year>2020</year>
            <month>Aug</month>
            <day>03</day>
            <volume>3</volume>
            <issue>8</issue>
            <fpage>e2013456</fpage>
            <pub-id pub-id-type="pmid">32797175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klaman</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Isaacs</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Leopold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perpich</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vender</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Campopiano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>HE</given-names>
              </name>
            </person-group>
            <article-title>Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.</article-title>
            <source>J Addict Med</source>
            <year>2017</year>
            <season>May/Jun</season>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>178</fpage>
            <page-range>178-190</page-range>
            <pub-id pub-id-type="pmid">28406856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Minozzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Amato</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jahanfar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bellisario</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ferri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Davoli</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Maintenance agonist treatments for opiate-dependent pregnant women.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2020</year>
            <month>Nov</month>
            <day>09</day>
            <volume>11</volume>
            <issue>11</issue>
            <fpage>CD006318</fpage>
            <pub-id pub-id-type="pmid">33165953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Noormohammadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Forinash</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yancey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Crannage</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shyken</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.</article-title>
            <source>Ann Pharmacother</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>50</volume>
            <issue>8</issue>
            <fpage>666</fpage>
            <page-range>666-72</page-range>
            <pub-id pub-id-type="pmid">27199497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Kaltenbach</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Heil</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Stine</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Coyle</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Arria</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>O'Grady</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Selby</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Neonatal abstinence syndrome after methadone or buprenorphine exposure.</article-title>
            <source>N Engl J Med</source>
            <year>2010</year>
            <month>Dec</month>
            <day>09</day>
            <volume>363</volume>
            <issue>24</issue>
            <fpage>2320</fpage>
            <page-range>2320-31</page-range>
            <pub-id pub-id-type="pmid">21142534</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Meltzer-Brody</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Evaluation and management of opioid dependence in pregnancy.</article-title>
            <source>Psychosomatics</source>
            <year>2012</year>
            <season>Sep-Oct</season>
            <volume>53</volume>
            <issue>5</issue>
            <fpage>424</fpage>
            <page-range>424-32</page-range>
            <pub-id pub-id-type="pmid">22902085</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakhireva</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Holbrook</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Shrestha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leyva</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ashley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stephen</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Leeman</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.</article-title>
            <source>Early Hum Dev</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>128</volume>
            <fpage>69</fpage>
            <page-range>69-76</page-range>
            <pub-id pub-id-type="pmid">30554024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lafferty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boelig</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Carola</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Adeniyi-Jones</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kraft</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Greenspan</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Aghai</surname>
                <given-names>ZH</given-names>
              </name>
            </person-group>
            <article-title>Is Maternal Methadone Dose Associated with the Severity of Neonatal Abstinence Syndrome?</article-title>
            <source>Am J Perinatol</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>10</issue>
            <fpage>1138</fpage>
            <page-range>1138-1144</page-range>
            <pub-id pub-id-type="pmid">33321531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pizarro</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Habli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bombrys</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sibai</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Livingston</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Higher maternal doses of methadone does not increase neonatal abstinence syndrome.</article-title>
            <source>J Subst Abuse Treat</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>295</fpage>
            <page-range>295-8</page-range>
            <pub-id pub-id-type="pmid">21255960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holmes</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Schmidlin</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Kurzum</surname>
                <given-names>EN</given-names>
              </name>
            </person-group>
            <article-title>Breastfeeding Considerations for Mothers of Infants with Neonatal Abstinence Syndrome.</article-title>
            <source>Pharmacotherapy</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>37</volume>
            <issue>7</issue>
            <fpage>861</fpage>
            <page-range>861-869</page-range>
            <pub-id pub-id-type="pmid">28488805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Qiao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brownell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Recto</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cleveland</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gelfond</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McGlothen-Bell</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>A Meta-Analysis of Breastfeeding Effects for Infants With Neonatal Abstinence Syndrome.</article-title>
            <source>Nurs Res</source>
            <string-date>2022 Jan-Feb 01</string-date>
            <volume>71</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-65</page-range>
            <pub-id pub-id-type="pmid">34596065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Graves</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Cannabis and breastfeeding.</article-title>
            <source>Paediatr Child Health</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>Suppl 1</issue>
            <fpage>S26</fpage>
            <page-range>S26-S28</page-range>
            <pub-id pub-id-type="pmid">32581628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mast</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Mother-to-infant hepatitis C virus transmission and breastfeeding.</article-title>
            <source>Adv Exp Med Biol</source>
            <year>2004</year>
            <volume>554</volume>
            <fpage>211</fpage>
            <page-range>211-6</page-range>
            <pub-id pub-id-type="pmid">15384578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bansaccal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Van der Linden</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Marot</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Belkhir</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>HIV-Infected Mothers Who Decide to Breastfeed Their Infants Under Close Supervision in Belgium: About Two Cases.</article-title>
            <source>Front Pediatr</source>
            <year>2020</year>
            <volume>8</volume>
            <fpage>248</fpage>
            <pub-id pub-id-type="pmid">32537442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schiff</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Terplan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hood</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bernson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Diop</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bharel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wilens</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>LaRochelle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walley</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Land</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>132</volume>
            <issue>2</issue>
            <fpage>466</fpage>
            <page-range>466-474</page-range>
            <pub-id pub-id-type="pmid">29995730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nanninga</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Weiland</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Feijen-de Jong</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Erwich</surname>
                <given-names>JJHM</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>LL</given-names>
              </name>
            </person-group>
            <article-title>Adverse Maternal and Infant Outcomes of Women Who Differ in Smoking Status: E-Cigarette and Tobacco Cigarette Users.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2023</year>
            <month>Feb</month>
            <day>01</day>
            <volume>20</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">36768007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Small</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brennan-Hunter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Porr</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The Understanding of Maternal Smoking among Women who were Smoking or had Quit Smoking during Pregnancy.</article-title>
            <source>Can J Nurs Res</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>250</fpage>
            <page-range>250-261</page-range>
            <pub-id pub-id-type="pmid">36214102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gustavson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ystrom</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stoltenberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Susser</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sur&#x000e9;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Magnus</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knudsen</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Langley</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rutter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aase</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Reichborn-Kjennerud</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Smoking in Pregnancy and Child ADHD.</article-title>
            <source>Pediatrics</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>139</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">28138005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Metz</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Borgelt</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Marijuana Use in Pregnancy and While Breastfeeding.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>132</volume>
            <issue>5</issue>
            <fpage>1198</fpage>
            <page-range>1198-1210</page-range>
            <pub-id pub-id-type="pmid">30234728</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luke</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hobbs</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Riddell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Agborsangaya</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cantin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fahey</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Der</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pederson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>C</given-names>
              </name>
              <collab>National Maternal Cannabis Working Group</collab>
            </person-group>
            <article-title>Cannabis use in pregnancy and maternal and infant outcomes: A Canadian cross-jurisdictional population-based cohort study.</article-title>
            <source>PLoS One</source>
            <year>2022</year>
            <volume>17</volume>
            <issue>11</issue>
            <fpage>e0276824</fpage>
            <pub-id pub-id-type="pmid">36417349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conner</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Bedell</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lipsey</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Macones</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Cahill</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Tuuli</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysis.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>128</volume>
            <issue>4</issue>
            <fpage>713</fpage>
            <page-range>713-723</page-range>
            <pub-id pub-id-type="pmid">27607879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marchand</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Masoud</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Govindan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ware</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ruther</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brazil</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ulibarri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Parise</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Arroyo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Coriell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Goetz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karrys</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sainz</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Birth Outcomes of Neonates Exposed to Marijuana in Utero: A Systematic Review and Meta-analysis.</article-title>
            <source>JAMA Netw Open</source>
            <year>2022</year>
            <month>Jan</month>
            <day>04</day>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>e2145653</fpage>
            <pub-id pub-id-type="pmid">35084479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ko</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Farr</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Creanga</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Callaghan</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>213</volume>
            <issue>2</issue>
            <fpage>201.e1</fpage>
            <page-range>201.e1-201.e10</page-range>
            <pub-id pub-id-type="pmid">25772211</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Plessinger</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Maternal, placental, and fetal pathophysiology of cocaine exposure during pregnancy.</article-title>
            <source>Clin Obstet Gynecol</source>
            <year>1993</year>
            <month>Jun</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>267</fpage>
            <page-range>267-78</page-range>
            <pub-id pub-id-type="pmid">8513624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gouin</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>PS</given-names>
              </name>
              <collab>Knowledge Synthesis group on Determinants of Low Birth Weight and Preterm Births</collab>
            </person-group>
            <article-title>Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>204</volume>
            <issue>4</issue>
            <fpage>340.e1</fpage>
            <page-range>340.e1-12</page-range>
            <pub-id pub-id-type="pmid">21257143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bada</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Shankaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lester</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Verter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smeriglio</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Finnegan</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Maza</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Gestational cocaine exposure and intrauterine growth: maternal lifestyle study.</article-title>
            <source>Obstet Gynecol</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>100</volume>
            <issue>5 Pt 1</issue>
            <fpage>916</fpage>
            <page-range>916-24</page-range>
            <pub-id pub-id-type="pmid">12423853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gorman</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Orme</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Kent</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Caughey</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Outcomes in pregnancies complicated by methamphetamine use.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>211</volume>
            <issue>4</issue>
            <fpage>429.e1</fpage>
            <page-range>429.e1-7</page-range>
            <pub-id pub-id-type="pmid">24905417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patrick</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Barfield</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Poindexter</surname>
                <given-names>BB</given-names>
              </name>
              <collab>COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION</collab>
            </person-group>
            <article-title>Neonatal Opioid Withdrawal Syndrome.</article-title>
            <source>Pediatrics</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>146</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">33106341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>N&#x000f8;rgaard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nielsson</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Heide-J&#x000f8;rgensen</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Birth and Neonatal Outcomes Following Opioid Use in Pregnancy: A Danish Population-Based Study.</article-title>
            <source>Subst Abuse</source>
            <year>2015</year>
            <volume>9</volume>
            <issue>Suppl 2</issue>
            <fpage>5</fpage>
            <page-range>5-11</page-range>
            <pub-id pub-id-type="pmid">26512202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cleary</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Donnelly</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Strawbridge</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Gallagher</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Fahey</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Methadone and perinatal outcomes: a retrospective cohort study.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>204</volume>
            <issue>2</issue>
            <fpage>139.e1</fpage>
            <page-range>139.e1-9</page-range>
            <pub-id pub-id-type="pmid">21145035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mactier</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shipton</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dryden</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tappin</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Reduced fetal growth in methadone-maintained pregnancies is not fully explained by smoking or socio-economic deprivation.</article-title>
            <source>Addiction</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>109</volume>
            <issue>3</issue>
            <fpage>482</fpage>
            <page-range>482-8</page-range>
            <pub-id pub-id-type="pmid">24321028</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morton Ninomiya</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Almomani</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dunbar Winsor</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Harding</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Ropson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chaves</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wolfson</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Supporting pregnant and parenting women who use alcohol during pregnancy: A scoping review of trauma-informed approaches.</article-title>
            <source>Womens Health (Lond)</source>
            <year>2023</year>
            <season>Jan-Dec</season>
            <volume>19</volume>
            <fpage>17455057221148304</fpage>
            <pub-id pub-id-type="pmid">36744547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36546.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goodman</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Improving Access to Maternity Care for Women with Opioid Use Disorders: Colocation of Midwifery Services at an Addiction Treatment Program.</article-title>
            <source>J Midwifery Womens Health</source>
            <year>2015</year>
            <season>Nov-Dec</season>
            <volume>60</volume>
            <issue>6</issue>
            <fpage>706</fpage>
            <page-range>706-12</page-range>
            <pub-id pub-id-type="pmid">26769383</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
